Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
ELEFANTE MICHAEL B (CIK 1053912) reported $91.5M across 109 reported positions in its SEC 13F filing for 2014-12-31. Largest positions: CVS ($3.7M, 4.04%), PG ($3.2M, 3.53%), JNJ ($3.2M, 3.49%), NVS ($3.1M, 3.36%), CNI ($2.9M, 3.21%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CVS | CVS HEALTH | $3.7M | 4.04% | 38,371 | Trimmed |
| 2 | PG | PROCTER & GAMBLE | $3.2M | 3.53% | 35,450 | Trimmed |
| 3 | JNJ | JOHNSON & JOHNSON | $3.2M | 3.49% | 30,555 | Trimmed |
| 4 | NVS | NOVARTIS AG ADR | $3.1M | 3.36% | 33,165 | Trimmed |
| 5 | CNI | CANADIAN NATL RAILWAY | $2.9M | 3.21% | 42,560 | Trimmed |
| 6 | MMM | 3M | $2.9M | 3.12% | 17,368 | Trimmed |
| 7 | XOM | EXXON MOBIL | $2.8M | 3.01% | 29,834 | Trimmed |
| 8 | AAPL | APPLE INC | $2.6M | 2.84% | 23,548 | Trimmed |
| 9 | NSRGY | NESTLE SA ADR | $2.5M | 2.79% | 34,941 | Trimmed |
| 10 | EMR | EMERSON ELECTRIC | $2.5M | 2.79% | 41,310 | Trimmed |
| 11 | ATR | APTARGROUP | $2.4M | 2.64% | 36,180 | Trimmed |
| 12 | MA | MASTERCARD | $2.3M | 2.56% | 27,130 | Trimmed |
| 13 | ADP | AUTOMATIC DATA PROCESSING | $2.3M | 2.53% | 27,785 | Trimmed |
| 14 | INTC | INTEL CORP | $2.0M | 2.17% | 54,810 | Trimmed |
| 15 | NOVOZYMES A S DKK 2.0 | $2.0M | 2.17% | 46,985 | Trimmed | |
| 16 | FISV | FISERV | $2.0M | 2.16% | 27,785 | Trimmed |
| 17 | EMC | E M C CORP MASS | $1.9M | 2.13% | 65,433 | Trimmed |
| 18 | ORCL | ORACLE | $1.8M | 1.99% | 40,389 | Trimmed |
| 19 | QCOM | QUALCOMM | $1.8M | 1.92% | 23,585 | Trimmed |
| 20 | NXPI | NXP SEMICONDUCTORS | $1.7M | 1.84% | 22,020 | Trimmed |
| 21 | PEP | PEPSICO | $1.6M | 1.76% | 17,069 | Trimmed |
| 22 | CVX | CHEVRON | $1.6M | 1.76% | 14,321 | Trimmed |
| 23 | RTX | UNITED TECHNOLOGIES | $1.6M | 1.76% | 13,996 | Trimmed |
| 24 | JCI | JOHNSON CONTROLS | $1.5M | 1.68% | 31,865 | Trimmed |
| 25 | ABT | ABBOTT LABS | $1.5M | 1.68% | 34,115 | Trimmed |
Source: SEC Form 13F filings · as of 2014-12-31